Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.

@article{Pilgrim2014UltrathinSB,
  title={Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.},
  author={Thomas Pilgrim and Dik Heg and Marco Roffi and David Tueller and Olivier Muller and Andre Georges Vuilliomenet and St{\'e}phane Cook and Daniel Weilenmann and Christoph Kaiser and Peiman Jamshidi and Therese Fahrni and Aris Moschovitis and Stephane L Noble and Franz Robert Eberli and Peter M. Wenaweser and Peter J{\"u}ni and Stephan Windecker},
  journal={Lancet},
  year={2014},
  volume={384 9960},
  pages={2111-22}
}
BACKGROUND Refinements in stent design affecting strut thickness, surface polymer, and drug release have improved clinical outcomes of drug-eluting stents. We aimed to compare the safety and efficacy of a novel, ultrathin strut cobalt-chromium stent releasing sirolimus from a biodegradable polymer with a thin strut durable polymer everolimus-eluting stent. METHODS We did a randomised, single-blind, non-inferiority trial with minimum exclusion criteria at nine hospitals in Switzerland. We… CONTINUE READING
52 Citations
40 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly)

  • A de Belder, JM de la Torre Hernandez, R Lopez-Palop
  • J Am Coll Cardiol
  • 2014

The 3-year results from the COMPARE II trial

  • PC Smits
  • EuroPCR
  • 2014

Similar Papers

Loading similar papers…